Chia (Salvia hispanica)-supplemented diet ameliorates non-alcoholic fatty liver disease and its metabolic abnormalities in humans.

Aida Medina-UrrutiaAngel R Lopez-UribeMohamed El HafidiMaria Del Carmen González-SalazarRosalinda Posadas-SánchezEsteban Jorge-GalarzaLeonardo Del Valle-MondragónJuan Gabriel Juárez-Rojas

Published in: Lipids in health and disease (2020)

The results of the present study show that 25 g/day of milled chia ameliorates NAFLD. Chia is an accessible vegetal source of omega-3 fatty acids, antioxidants, and fiber, which could have the potential to prevent metabolic abnormalities in NAFLD patients. Considering that there is no pharmacological treatment approved for NAFLD, the findings of the present study suggest that a chia-supplemented diet could be an innovative alternative to control this disease. RETROSPECTIVELY REGISTERED: https://clinicaltrials.gov/show/NCT03942822.

Keyphrases

end stage renal disease
physical activity
fatty acid
weight loss
mouse model
ejection fraction
newly diagnosed
peritoneal dialysis
risk assessment
climate change